Will America’s “healthy reflation” end in inflation?
Democratic control of the US Congress would give Joe Biden huge scope to stimulate the economy. But willie mean a “healthy reflation” for the economy or will things go too far, triggering inflation?

Has the stockmarket caught vertigo? US indices ended 2020 on record highs, with the S&P 500 registering a 16.3% gain for the year. The tech-heavy Nasdaq soared by 43.6%, its best annual performance since 2009. The end-of-year cheer was helped by last-minute agreement on a $900bn pandemic stimulus package in Washington. But things reversed on the first trading day of 2021: the S&P 500 fell back 1.5%, its biggest one-day drop since the end of October.
Stocks wobble…
By mid-week traders were digesting the results of two tight elections in Georgia that looked likely to give the Democrats control of the US Senate. The prospect of Democrats taking the “trifecta” of the White House and both houses of Congress raises the risk of tech regulation, says Randall Forsyth in Barron’s. The “blue wave” is back and with it memories of September when tech stocks tumbled back to earth. Nasdaq futures contracts fell by more than 1% in response to the results.
Equity markets remain generally bullish, but don’t expect a smooth ride this year, says Michael Mackenzie in the Financial Times. US valuations are more stretched than they were a year ago – never mind the small matter of a pandemic. In some ways this is a “rational bubble”: ultra-loose monetary policy pushes even reluctant investors into the stockmarket in search of returns. The general direction may be up, but at these levels highly strung stock prices are acutely sensitive to bad news. I expect at least one “serious wobble at some point” over the coming 12 months.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The market is “fussing” over the Georgia elections, says Stephen Innes of Axi. Things are likely to settle once Wall Street digests the news. Biden’s administration has no intention of raising taxes in the near-term for fear of killing the recovery and spending is set to soar. Before too long resolutely bullish traders will have concluded that this is “close to a best-case scenario”.
... but the real action is in bonds
Democratic control of Congress would give Biden “huge scope” to stimulate the economy, writes Liam Halligan in The Sunday Telegraph. He has suggested a “vast infrastructure programme” to renovate roads and airports that could cost about $3trn. The market could end up cheering all the extra cash, but an additional “lather” of stimulus on top of already unprecedented monetary support will leave markets “deep in bubble territory and detached from reality”. The likelihood of more US government spending sent ten-year Treasury yields – the benchmark of the US government’s borrowing costs – above 1% for the time in nine months.
The key question now is whether all that stimulus means “healthy reflation” for the economy or whether things go too far, triggering inflation, says John Authers on Bloomberg. There are certainly reasons to worry. Commodity prices have spiked. The US savings rate hasn’t been this high since the 1970s, which could bring a consumer spending wave later this year that will push up prices. Democrat control of the Senate makes inflation more likely, not less.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Ben Cohen: The Ben & Jerry’s co-founder who wants to break away from Unilever
Ben Cohen of Ben & Jerry’s ice cream is seeking to break away from Unilever, the conglomerate he sold out to in 2000. It’s a battle for the soul of the brand synonymous with corporate do-gooding.
By Jane Lewis
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine